Hallucinogen abuse with other hallucinogen-induced disorder
ICD-10 F16.188 is a billable code used to indicate a diagnosis of hallucinogen abuse with other hallucinogen-induced disorder.
F16.188 refers to a condition characterized by the abuse of hallucinogenic substances, leading to various psychological and physiological disorders. Hallucinogens, such as LSD, psilocybin, and mescaline, can induce altered states of perception, mood, and cognitive function. When an individual abuses these substances, they may experience a range of hallucinogen-induced disorders, including persistent perceptual changes, anxiety, or psychosis. The diagnosis of F16.188 is applicable when the individual exhibits symptoms that do not fit neatly into other specific hallucinogen-induced disorders, indicating a more complex clinical picture. Treatment often involves a combination of behavioral therapies, counseling, and support groups, focusing on addressing both the substance use disorder and the associated psychological symptoms. Clinicians must carefully document the patient's history, substance use patterns, and any co-occurring mental health conditions to ensure accurate coding and effective treatment planning.
Detailed patient history, including substance use patterns and mental health evaluations.
Patients presenting with acute psychosis or anxiety following hallucinogen use.
Consideration of co-occurring disorders and the need for a multidisciplinary approach.
Comprehensive assessment of substance use, including frequency, duration, and impact on functioning.
Patients in withdrawal or seeking treatment for hallucinogen dependence.
Integration of behavioral therapies and support systems in treatment plans.
Used during initial evaluation of a patient with suspected hallucinogen abuse.
Comprehensive assessment notes detailing substance use history and mental health status.
Psychiatric evaluations should include specific inquiries about hallucinogen use.
Common symptoms include visual and auditory hallucinations, altered sense of time, mood swings, anxiety, and cognitive disturbances. These symptoms can vary based on the specific hallucinogen used and the individual's mental health history.
